0001104659-22-047211.txt : 20220419
0001104659-22-047211.hdr.sgml : 20220419
20220419125447
ACCESSION NUMBER: 0001104659-22-047211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220415
FILED AS OF DATE: 20220419
DATE AS OF CHANGE: 20220419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gaal Lubor
CENTRAL INDEX KEY: 0001822638
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37411
FILM NUMBER: 22834122
MAIL ADDRESS:
STREET 1: C/O TIMBER PHARMACEUTICALS, INC.
STREET 2: 900 E. HAMILTON AVENUE, SUITE 100
CITY: CAMPBELL
STATE: CA
ZIP: 95008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Timber Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001504167
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593843182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 ALLEN ROAD, SUITE 401
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
BUSINESS PHONE: 914-205-3481
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD, SUITE 401
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharmX Corp
DATE OF NAME CHANGE: 20140304
FORMER COMPANY:
FORMER CONFORMED NAME: THOMPSON DESIGNS INC
DATE OF NAME CHANGE: 20101022
4
1
tm2212708-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-04-15
0
0001504167
Timber Pharmaceuticals, Inc.
TMBR
0001822638
Gaal Lubor
C/O TIMBER PHARMACEUTICALS, INC
110 ALLEN ROAD, SUITE 401
BASKING RIDGE
NJ
07920
1
0
0
0
Common Stock, par value $0.001 per share
2022-04-15
4
A
0
100000
0
A
100000
D
Stock Option (right to buy)
0.307
2022-04-15
4
A
0
100000
0
A
2032-04-14
Common Stock, par value $0.001 per share
100000
100000
D
On April 15, 2022, the Reporting Person was granted 100,000 restricted stock units, which will be settled in shares of common stock, par value $0.001, of Timber Pharmaceuticals, Inc. (the "Issuer"). The restricted stock units vest in 12 equal monthly installments beginning on May 15, 2022, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date.
25% of the options vest on April 15, 2023, and the remaining shares will become exercisable in 24 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date.
/s/ Joseph Lucchese, Power of Attorney
2022-04-19